These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12415090)

  • 1. Possible functional regression of insulinoma with prolonged octreotide.
    Craig CE; Gallen IW
    Postgrad Med J; 2002 Oct; 78(924):623-4. PubMed ID: 12415090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of benign insulinoma using octreotide LAR: a case report.
    Usukura M; Yoneda T; Oda N; Yamamoto Y; Takata H; Hasatani K; Takeda Y
    Endocr J; 2007 Feb; 54(1):95-101. PubMed ID: 17124362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-responsive and octreotide-sensitive insulinoma.
    Izumiyama H; Gotyo N; Fukai N; Ozawa N; Doi M; Yoshimoto T; Arii S; Hirata Y
    Intern Med; 2006; 45(8):519-24. PubMed ID: 16702744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma.
    Katabami T; Kato H; Shirai N; Naito S; Saito N
    Endocr J; 2005 Oct; 52(5):629-34. PubMed ID: 16284444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
    Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
    Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients.
    Kishikawa H; Okada Y; Hirose A; Tanikawa T; Kanda K; Tanaka Y
    Endocr J; 2006 Feb; 53(1):79-85. PubMed ID: 16543676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic usefulness of radiolabeled pentetreotide scintigraphy and therapeutic efficiency of octreotide in a case of insulinoma.
    Cuvelier C; Pochet JM; Col V; Jonard P; Pauwels S; Cuvelier A
    Acta Clin Belg; 1994; 49(6):296-301. PubMed ID: 7871936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of malignant insulin-producing pancreatic tumor treatment].
    Reutova EV; Orel NF; Besova NS; Artemova EV; Smirnova NB; Gorbunova VA
    Ter Arkh; 1999; 71(10):44-5. PubMed ID: 10612174
    [No Abstract]   [Full Text] [Related]  

  • 9. No effect of the long-acting somatostatin analogue octreotide in patients with insulinoma.
    Timmer R; Koningsberger JC; Erkelens DW; Thijssen JH; Lips CJ; Koppeschaar HP
    Neth J Med; 1991 Jun; 38(5-6):199-203. PubMed ID: 1922592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH; Naafs MA
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):34-40. PubMed ID: 2545062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: report of a case.
    Tanaka Y; Funahashi H; Imai T; Naruse T; Suzumura K; Oda Y
    Surg Today; 2000; 30(6):541-3. PubMed ID: 10883468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the long-acting somatostatin analogue octreotide in the management of insulinoma in three dogs.
    Simpson KW; Stepien RL; Elwood CM; Boswood A; Vaillant CR
    J Small Anim Pract; 1995 Apr; 36(4):161-5. PubMed ID: 7603057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of Sandostatin in the combined treatment of surgical diseases of the pancreas].
    Saenko VF; Lifshits IuZ; Kozhara SP; Usenko AIu; Andreeshchev SA; Kryzhevskiĭ VV; Olenin VV; Beliaeva OA
    Lik Sprava; 1997; (3):126-7. PubMed ID: 9377332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinoma revealed by recurrent falls in old age.
    Beauchet O; Kressig RW; Vischer UM; de Perrot T; de Saussure P
    J Am Geriatr Soc; 2005 Mar; 53(3):552-3. PubMed ID: 15743313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Benign insulinoma. Efficacy of preoperative treatment for persistent hyperinsulinemia using a synthetic somatostatin analog].
    Esposito V; Esposito D; Lo Iudice G; Rispoli C; Verrillo A; D'Alessandro B
    Minerva Endocrinol; 1994 Mar; 19(1):33-7. PubMed ID: 8035768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
    Glaser B; Rösler A; Halperin Y
    Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
    Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
    Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of hypoglycemia with octreotide therapy in metastatic insulinoma with positive octreotide scan.
    Wade AN; Cheng G; Teitelbaum U; Patel AA; Alavi A; Rickels MR
    Pancreas; 2011 Jan; 40(1):173-5. PubMed ID: 21160385
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic remission with octreotide in patients with insulinoma.
    von Eyben FE; Grodum E; Gjessing HJ; Hagen C; Nielsen H
    J Intern Med; 1994 Mar; 235(3):245-8. PubMed ID: 8120520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.